FDA delays decision on Moderna coronavirus vaccine for adolescents to evaluate myocarditis risk company says – The Washington Post

The agencys action comes after several countries, including Japan and Nordic nations, raised concerns that the Moderna vaccine increases the risk of myocarditis in men 18 to 30. In Finland and Sweden… [read more]

Leave a Reply

Your email address will not be published. Required fields are marked *